Multiple sclerosis following splenectomy as a treatment for idiopathic thrombocytopenic purpura

Internal Medicine

Volumn 44, Issue 7, 2005, Pages 747-749

  Matsui, Hideaki ^a   Udaka, Fukashi ^a   Tamura, Akiko ^a   Oda, Masaya ^a   Kubori, Tamotsu ^a   Nishinaka, Kazuto ^a   Kameyama, Masakuni ^a  

^a SUMITOMO HOSPITAL   (Japan)

Author keywords

Autoimmune disorders; Idiopathic thrombocytopenic purpura; Multiple sclerosis; Splenectomy; T cell

Indexed keywords

CORTICOSTEROID; PREDNISOLONE; STEROID;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BREAST; CASE REPORT; CELL ACTIVITY; DRUG PULSE THERAPY; DYSESTHESIA; DYSPNEA; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HYPESTHESIA; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MULTIPLE SCLEROSIS; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; QUADRIPLEGIA; SPLENECTOMY; STEROID THERAPY; SYMPTOMATOLOGY; TH1 CELL; TH2 CELL; URINARY TRACT DISEASE; VISUAL IMPAIRMENT;

ADULT; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; OPTIC NERVE; PHENOTYPE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SPLENECTOMY;

EID: 23244441588     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.747     Document Type: Article

References (14)

1. Best WR, Darling DR. A critical look at the splenectomy - S.L.E. controversy. Med Clin North Am 46: 19-47, 1962.
2. Spirer Z, Hauser GJ, Hazaz B, Joshua H. Autoimmune antibodies after splenectomy. Acta Haemat 63: 230-233, 1980.
3. Semple JW, Milev Y, Cosgrave D, et al. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship platelet phenotype and antiplatelet T-cell reactivity. Blood 87: 4245-4254, 1996.
4. Kuwana M, Kaburaki J, Kitasato H, et al. Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura. Blood 98: 130-139, 2001.
5. Weiner HL. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. Arch Neurol 61: 1613-1615, 2004.
6. Chaudhuri A, Behan PO. Multiple sclerosis is not an autoimmune disease. Arch Neurol 61: 1610-1612, 2004.
7. McMillan R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol 37: 239-248, 2000.
8. Mazzucconi MG, Arista MC, Peraino M, et al. Long-term follow-up of autoimmune thrombocytopenic purpura (ATP) patients submitted to splenectomy. Eur J Haematol 62: 219-222, 1999.
9. Aster RH, George JN, McMillan R, Ganguly P. Workshop on autoimmune (idiopathic) thrombocytopenic purpura: pathogenesis and new approaches to therapy. Am J Hematol 58: 231-234, 1998.
10. Kuwana M, Okazaki Y, Kaburaki J, Kawakami Y, Ikeda Y. Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpura. J Immunol 168: 3675-3682, 2002.
11. Mazzucconi MG, Piola P, Arista MC, Bizzoni L, Antenucci A, Conti L. Modifications of lymphocyte subsets in autoimmune thrombocytopenic purpura patients submitted to splenectomy. Haematologica 85: 776-777, 2000.
12. Allison AC, Denman AM, Barnes RD. Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet 2: 135-140, 1971.
13. Sampson D, Grotelueschen C, Kauffman HM Jr. The human splenic suppressor cell. Transplantation 20: 362-367, 1975.
14. Sampson D, Kauffman HM Jr, Grotelueschen C, Metzig J. Suppressor activity of the human spleen and thymus. Surgery 79: 393-397, 1976.